Black Box Warning Strengthened On Anemia Drugs

Law360, New York (March 10, 2008, 12:00 AM EDT) -- A group of flagship anemia drugs used in chemotherapy will carry stronger warnings about lethal dangers the drugs pose to patients with certain types of cancer, drugmakers said Friday.

Aranesp, Epogen and Procrit will carry updated black box warnings that the drugs may hasten death and accelerate the growth of tumors in patients with some types of cancer, after studies confirmed the U.S. Food and Drug Administration's questions about the drugs' safety.

The drugs, known as erythropoiesis-stimulating agents, are commonly used to treat anemia caused by...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.